bevacizumab,cetuximab,irinotecan
roche,eli lilly
 the bardelli research may well become relevant soon (msi pts, post egfr). as there are 3 types of vitamin c responders, would like to see breakdown of cornell trial. fire 3 did show different outcomes. as a chemo holiday strategy, vitamin c might have benefit... for some.
volunteer #CRCSM librarian
#BRAF & #NRAS FB grps
Stage 4 CRC Support & Colon Cancer Stars
trials Stage 2/3 pts
https://t.co/48vU5493pH